Rodgers, Samuel J.
Ooms, Lisa M. http://orcid.org/0000-0002-8918-9932
Oorschot, Viola M. J.
Schittenhelm, Ralf B. http://orcid.org/0000-0001-8738-1878
Nguyen, Elizabeth V.
Hamila, Sabryn A.
Rynkiewicz, Natalie
Gurung, Rajendra
Eramo, Matthew J.
Sriratana, Absorn
Fedele, Clare G.
Caramia, Franco http://orcid.org/0000-0002-5086-2544
Loi, Sherene http://orcid.org/0000-0001-6137-9171
Kerr, Genevieve
Abud, Helen E. http://orcid.org/0000-0003-3792-4023
Ramm, Georg http://orcid.org/0000-0003-3596-2288
Papa, Antonella http://orcid.org/0000-0001-8653-7121
Ellisdon, Andrew M.
Daly, Roger J. http://orcid.org/0000-0002-5739-8027
McLean, Catriona A. http://orcid.org/0000-0002-0302-5727
Mitchell, Christina A. http://orcid.org/0000-0001-9372-3192
Article History
Received: 6 October 2020
Accepted: 16 April 2021
First Online: 25 May 2021
Competing interests
: C.A. Mitchell., S.J.R., and L.M.O. are inventors on a planned patent application relating to the use of Wnt inhibitors for breast cancers with increased INPP4B expression. The remaining authors declare no competing interests.